ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)

TYO:4886 Revenue

In the fiscal year ending March 31, 2026, ASKA Pharmaceutical Holdings had annual revenue of 71.13B JPY with 10.90% growth. ASKA Pharmaceutical Holdings had revenue of 16.64B in the quarter ending March 31, 2026, with 17.08% growth.

• Revenue: 71.13B
• Revenue Growth: +10.90%
• P/S Ratio: 1.17
• Revenue / Employee: 43.58M
• Employees: 1,632
• Market Cap: 83.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	71.13B	6.99B	10.90%
Mar 31, 2025	64.14B	1.30B	2.06%
Mar 31, 2024	62.84B	2.38B	3.94%
Mar 31, 2023	60.46B	3.85B	6.81%
Mar 31, 2022	56.61B	1.43B	2.58%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error